IL6 and type 1 diabetes mellitus: Furthermore, the administration of SHP-1 inhibitor SSG into the mouse dorsal skin significantly increased the expression of TNF-α and IL-6 in the skin wounds of both WT normal and T1D mice (Fig. 4j).